openPR Logo
Press release

Companion Diagnostics Market to Reach US$ 9.30ย Billion by End of 2028, TMR Study

03-20-2024 08:31 AM CET | Health & Medicine

Press release from: Transparency Market Research

Companion Diagnostics

Companion Diagnostics

The global ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ข๐จ๐ง ๐๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ, valued at US$ 5.24 billion in 2020, is projected to grow at a CAGR of 9% from 2021 to 2028, reaching US$ 9.30 billion by 2028. Analysts anticipate significant growth driven by increasing incidences of oncology and chronic disorders worldwide. Despite promising revenue opportunities, challenges such as lengthy approval processes and limited reimbursement policies in certain regions may impede market expansion. Companion diagnostics play a crucial role in personalized medicine for cancer patients by assessing their response to targeted drug therapy.

๐†๐ž๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐…:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=387&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

Companion diagnostics are tests that help predict the effectiveness or safety of a therapeutic treatment for individuals with certain diseases. They assist physicians in making treatment decisions by determining the efficacy of a specific drug for a particular patient population. For example, Herceptin (trastuzumab) is used to treat breast cancer patients with the HER2 gene.

These diagnostics are poised for significant growth due to numerous tests in development. They offer the advantage of predicting patient response to therapy, leading to better outcomes and reduced healthcare costs. Additionally, they help avoid generic treatments, lowering the risk of side effects and hospitalizations.

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐จ๐ง ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: ๐Š๐ž๐ฒ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ

Technological advancements, increased cancer prevalence worldwide, and ongoing research and development efforts are expected to drive growth in the global companion diagnostics market.

Demand for personalized medicines and expansion of the pharmaceutical industry, along with key mergers and acquisitions, will contribute to market expansion.

The impact of COVID-19 on companion diagnostics is also projected to boost market growth during the forecast period.

The rising prevalence of infectious diseases like HIV will further drive demand for advanced companion diagnostics.

Breast cancer incidence is on the rise globally, particularly in both developing and developed countries, which will significantly impact the market.

Major risk factors for cancer include hereditary factors, aging, obesity, high alcohol consumption, hormone replacement therapy, and cosmetic implants.
Technological advancements leading to faster approval of companion diagnostic tests will be a key driver for market growth.

Regulatory approvals for companion diagnostic assays, with around 44 CDx assays approved by the FDA in 2020 alone, are expected to propel the market forward in the coming years.

๐Œ๐š๐ฃ๐จ๐ซ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

Labcorp Drug Development,Agilent Technologies,Myriad Genetic Laboratories, Inc.,Qiagen,Roche Molecular Systems, Inc.,Dako, Inc.,Abbott,Foundation Medicine, Inc.,MolecularMD Corporation,Ventana Medical Systems, Inc.,Illumina, Inc.,Life Technologies Corporation,Invivoscribe Technologies, Inc.,ARUP Laboratories, Inc.,Leica Biosystems,Biogenex Laboratories, Inc.,bioMรฉrieux, Inc.,GE Healthcare,Agendia N.V,Exact Sciences Corp,Genomic Health

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

By Indication

Breast Cancer
Lung Cancer
Colorectal Cancer
Gastric Cancer
Melanoma
Others (HIV, Thalassemia)

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ: ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐จ๐ง ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

North America dominated the global companion diagnostics market in 2020 and is expected to maintain this trend in the forecast period, driven by technological advancements, growing patient population, and increasing cancer prevalence.

The region saw 1,806,590 new cancer cases and 606,520 deaths in 2020, highlighting the demand for companion diagnostics in North America.

Asia Pacific is poised for rapid growth due to rising cancer rates, the COVID-19 pandemic, and advancements in diagnostic products. Breast cancer cases will particularly drive the market.

Increased demand for personalized medicines, along with untapped potential, scientific research, economic growth, and favorable regulatory environments, make Asia Pacific attractive to global players.

๐†๐ž๐ญ ๐“๐ก๐ข๐ฌ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ, ๐ˆ๐ง๐ฌ๐ญ๐š๐ง๐ญ๐ฅ๐ฒ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=387<ype=S&utm_source=OpenPR&utm_campaign=MansiR_OpenPR

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ:

Integration of artificial intelligence and machine learning in companion diagnostics.

Expansion of companion diagnostics beyond oncology to other therapeutic areas.

Shift towards decentralized testing and point-of-care diagnostics.

๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:

The Companion Diagnostics Market is poised for continued growth, driven by ongoing technological innovations, expanding applications, and increasing adoption across various disease areas. As precision medicine becomes increasingly mainstream, companion diagnostics will play an indispensable role in optimizing treatment strategies and improving patient outcomes.

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ญ๐ฎ๐๐ฒ ๐๐จ๐ข๐ง๐ญ๐ฌ:

Market dynamics analysis, including drivers, challenges, opportunities, and trends.
Comprehensive market segmentation analysis.
Regional analysis highlighting growth opportunities and market trends.
Competitive landscape assessment, identifying key players, market strategies, and recent developments.
Future outlook and growth prospects.

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐Œ๐จ๐ซ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐“๐Œ๐‘:

๐€๐ฎ๐ญ๐จ๐ฆ๐จ๐ญ๐ข๐ฏ๐ž ๐Ž๐ข๐ฅ ๐๐ฎ๐ฆ๐ฉ ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2023/01/31/2598865/0/en/Automotive-Oil-Pump-Market-Estimated-to-Grow-at-a-CAGR-Of-4-5-from-2022-to-2031-as-per-TMR-Study.html

๐“๐ซ๐š๐œ๐ก๐ž๐จ๐ฌ๐ญ๐จ๐ฆ๐ฒ ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ- https://www.globenewswire.com/news-release/2023/01/31/2598797/0/en/Tracheostomy-Devices-Market-Value-to-Exceed-US-291-3-Million-by-2031-as-per-Transparency-Market-Research-Inc.html

๐€๐›๐จ๐ฎ๐ญ ๐“๐ซ๐š๐ง๐ฌ๐ฉ๐š๐ซ๐ž๐ง๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก

Transparency Market Research, a globalย market research companyย registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website:ย https://www.transparencymarketresearch.comย ย ย ย  ย ย 
Email:ย ย sales@transparencymarketresearch.com
Follow Us:ย LinkedIn|ย Twitter|ย Blogย |ย YouTube

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostics Market to Reach US$ 9.30ย Billion by End of 2028, TMR Study here

News-ID: 3437411 • Views: โ€ฆ

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 โ€ฆ
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends fromโ€ฆ
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra โ€ฆ
The global Technetiumโ€99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetiumโ€99mโ€ฆ
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to โ€ฆ
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equineโ€ฆ
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of โ€ฆ
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,โ€ฆ

All 5 Releases


More Releases for Companion

Companion Animal Medicine Market Healthy Companions, Healthy Profits: Trends in โ€ฆ
Companion Animal Medicine Market to reach over USD 41.71 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Medicine Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats, And Horses), Product (Pharmaceuticals And Medicated Feed Additives), Distribution Channel (Veterinary Hospitals And Clinics), And Indication (Antibiotics and Parasiticides)- Market Outlookโ€ฆ
Companion Diagnostics Market - Companion Diagnostics Industry Size, Share, Analy โ€ฆ
Companion diagnostics are medical devices and tests that provide essential information for the safe and effective use of a corresponding drug or biological product. These diagnostics are critical in the field of personalized medicine, as they help identify patients who are most likely to benefit from a particular therapeutic product. The Global Companion Diagnostics Market was valued at US$ 5.59 Billion in 2022 and is projected to reach US$ 13.74โ€ฆ
Companion Animal Digital Technology Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Companion Animal Digital Technology Market By Type of Service (Telemedicine, Telehealth, Reminder Applications, Trackers, Wearables, and Platform Market Places) Trends, Industry Competition Analysis, COVID-19 Impact Analysis, Revenue and Forecast Till 2031." features detailed market analysis and an extensive study on the current trends, exploring its significant factors. The Artificial Intelligence (AI) In Beauty and Cosmetics Marketโ€ฆ
Companion Diagnostics Market - Transforming Patient Outcomes: Pioneering Compani โ€ฆ
Newark, New Castle, USA: The "Companion Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Companion Diagnostics Market: https://www.growthplusreports.com/report/companion-diagnostics-market/8673 This latest report researches the industry structure, sales, revenue,โ€ฆ
Companion Animal Vaccine โ€“ Improving The Health Of Companion Animals In A Cost โ€ฆ
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the companyโ€™s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, theโ€ฆ
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016โ€“2024),ย as highlighted in a new report published by Coherent Market Insights.ย Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) testโ€ฆ